Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future
The Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent prioritization, preclinical therapeutics testing,...
| Published in: | Journal of Clinical and Translational Science |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2024-01-01
|
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S205986612400178X/type/journal_article |
| _version_ | 1850354044193734656 |
|---|---|
| author | Stacey J. Adam Timothy G. Buchman Judith S. Currier Ruxandra Draghia-Akli Josh P. Fessel Elizabeth S. Higgs Eric A. Hughes Lisa LaVange Joseph P. Menetski Sarah W. Read Yves Rosenberg Randall Tressler ACTIV Therapeutics-Clinical Working Group |
| author_facet | Stacey J. Adam Timothy G. Buchman Judith S. Currier Ruxandra Draghia-Akli Josh P. Fessel Elizabeth S. Higgs Eric A. Hughes Lisa LaVange Joseph P. Menetski Sarah W. Read Yves Rosenberg Randall Tressler ACTIV Therapeutics-Clinical Working Group |
| author_sort | Stacey J. Adam |
| collection | DOAJ |
| container_title | Journal of Clinical and Translational Science |
| description | The Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent prioritization, preclinical therapeutics testing, master protocol design and implementation, drug manufacturing and supply, data sharing, and public–private partnership value are shared to inform responses to future pandemics. |
| format | Article |
| id | doaj-art-a7c8b5fb4a0045bfa8f5cc35ccb6d74c |
| institution | Directory of Open Access Journals |
| issn | 2059-8661 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| spelling | doaj-art-a7c8b5fb4a0045bfa8f5cc35ccb6d74c2025-08-19T23:08:18ZengCambridge University PressJournal of Clinical and Translational Science2059-86612024-01-01810.1017/cts.2024.178Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J. Adam0https://orcid.org/0000-0002-4590-5175Timothy G. Buchman1Judith S. Currier2Ruxandra Draghia-Akli3Josh P. Fessel4Elizabeth S. Higgs5Eric A. Hughes6Lisa LaVange7Joseph P. Menetski8Sarah W. Read9https://orcid.org/0000-0003-3876-472XYves Rosenberg10Randall Tressler11ACTIV Therapeutics-Clinical Working GroupFoundation for the National Institutes of Health, North Bethesda, MD, USACritical Care Center, Emory University School of Medicine, Atlanta, GA, USADepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USAThe Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USANational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USANational Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USATeva Pharmaceuticals, Parsippany, NJ, USABiostatistics, Gillings School of Global Public Health at the University of North Carolina at Chapel Hill, NC, USAFoundation for the National Institutes of Health, North Bethesda, MD, USANational Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USANational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USANational Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USAThe Accelerating COVID-19 Therapeutic Interventions and Vaccines Therapeutic-Clinical Working Group members gathered critical recommendations in follow-up to lessons learned manuscripts released earlier in the COVID-19 pandemic. Lessons around agent prioritization, preclinical therapeutics testing, master protocol design and implementation, drug manufacturing and supply, data sharing, and public–private partnership value are shared to inform responses to future pandemics.https://www.cambridge.org/core/product/identifier/S205986612400178X/type/journal_articleCovid-19trialstherapeuticsmaster protocollessons learned |
| spellingShingle | Stacey J. Adam Timothy G. Buchman Judith S. Currier Ruxandra Draghia-Akli Josh P. Fessel Elizabeth S. Higgs Eric A. Hughes Lisa LaVange Joseph P. Menetski Sarah W. Read Yves Rosenberg Randall Tressler ACTIV Therapeutics-Clinical Working Group Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future Covid-19 trials therapeutics master protocol lessons learned |
| title | Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future |
| title_full | Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future |
| title_fullStr | Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future |
| title_full_unstemmed | Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future |
| title_short | Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future |
| title_sort | preparing better accelerating covid 19 therapeutic interventions and vaccines activ therapeutics trials lessons learned a call to the future |
| topic | Covid-19 trials therapeutics master protocol lessons learned |
| url | https://www.cambridge.org/core/product/identifier/S205986612400178X/type/journal_article |
| work_keys_str_mv | AT staceyjadam preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT timothygbuchman preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT judithscurrier preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT ruxandradraghiaakli preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT joshpfessel preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT elizabethshiggs preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT ericahughes preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT lisalavange preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT josephpmenetski preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT sarahwread preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT yvesrosenberg preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT randalltressler preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture AT activtherapeuticsclinicalworkinggroup preparingbetteracceleratingcovid19therapeuticinterventionsandvaccinesactivtherapeuticstrialslessonslearnedacalltothefuture |